51.61
price up icon0.52%   0.2101
 
loading
Precedente Chiudi:
$51.40
Aprire:
$51.89
Volume 24 ore:
4.19M
Relative Volume:
0.85
Capitalizzazione di mercato:
$9.23B
Reddito:
$1.27B
Utile/perdita netta:
$-245.03M
Rapporto P/E:
-36.68
EPS:
-1.4071
Flusso di cassa netto:
$-245.36M
1 W Prestazione:
-3.81%
1M Prestazione:
-3.52%
6M Prestazione:
-33.86%
1 anno Prestazione:
-2.02%
Intervallo 1D:
Value
$50.32
$52.48
Intervallo di 1 settimana:
Value
$48.75
$55.46
Portata 52W:
Value
$36.22
$104.32

Tempus Ai Inc Stock (TEM) Company Profile

Name
Nome
Tempus Ai Inc
Name
Telefono
800-976-5448
Name
Indirizzo
600 WEST CHICAGO AVENUE, CHICAGO
Name
Dipendente
3,800
Name
Cinguettio
Name
Prossima data di guadagno
2026-02-24
Name
Ultimi documenti SEC
Name
TEM's Discussions on Twitter

Compare TEM vs VEEV, BTSG, HQY, WAY

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Health Information Services icon
TEM
Tempus Ai Inc
51.62 9.19B 1.27B -245.03M -245.36M -1.4071
Health Information Services icon
VEEV
Veeva Systems Inc
187.05 30.56B 3.08B 860.33M 1.35B 5.1463
Health Information Services icon
BTSG
Brightspring Health Services Inc
41.71 7.33B 11.99B 24.18M 234.31M 0.2956
Health Information Services icon
HQY
Healthequity Inc
82.47 6.87B 1.15B 96.70M -161.99M 1.09
Health Information Services icon
WAY
Waystar Holding Corp
26.86 5.09B 906.14M -52.62M 89.62M -0.3621

Tempus Ai Inc Stock (TEM) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2026-02-19 Iniziato Mizuho Outperform
2026-02-17 Iniziato Robert W. Baird Outperform
2025-12-02 Ripresa Morgan Stanley Overweight
2025-10-21 Downgrade TD Cowen Buy → Hold
2025-10-20 Iniziato Canaccord Genuity Buy
2025-09-02 Iniziato H.C. Wainwright Buy
2025-04-21 Iniziato BTIG Research Buy
2025-02-25 Downgrade JP Morgan Overweight → Neutral
2025-02-12 Downgrade William Blair Outperform → Mkt Perform
2025-02-05 Ripresa TD Cowen Buy
2024-12-13 Iniziato Wolfe Research Outperform
2024-12-09 Iniziato Guggenheim Buy
2024-11-11 Downgrade Stifel Buy → Hold
2024-10-02 Downgrade BofA Securities Buy → Neutral
2024-08-12 Iniziato Piper Sandler Neutral
2024-07-09 Iniziato BofA Securities Buy
2024-07-09 Iniziato JP Morgan Overweight
2024-07-09 Iniziato Longbow Buy
2024-07-09 Iniziato Loop Capital Buy
2024-07-09 Iniziato Morgan Stanley Overweight
2024-07-09 Iniziato Needham Buy
2024-07-09 Iniziato Stifel Buy
2024-07-09 Iniziato TD Cowen Buy
2024-07-09 Iniziato William Blair Outperform
Mostra tutto

Tempus Ai Inc Borsa (TEM) Ultime notizie

pulisher
08:00 AM

What Does the Market Think About Tempus AI Inc? - Benzinga

08:00 AM
pulisher
06:16 AM

Tempus’ growth can’t shake Wall Street’s worries - Crain's Chicago Business

06:16 AM
pulisher
Mar 03, 2026

Tempus AI expands collaboration with Merck on precision medicine By Investing.com - Investing.com Australia

Mar 03, 2026
pulisher
Mar 03, 2026

AI-Powered Tempus Inks New Multi-Year Merck DealTempus AI (NASDAQ:TEM) - Benzinga

Mar 03, 2026
pulisher
Mar 03, 2026

Tempus AI (NASDAQ:TEM) Price Target Lowered to $70.00 at Morgan Stanley - MarketBeat

Mar 03, 2026
pulisher
Mar 03, 2026

Merck’s Oncology Results And Tempus AI Deal Reframe Post Keytruda Future - simplywall.st

Mar 03, 2026
pulisher
Mar 03, 2026

Hospital Networks Turn to AI-Enhanced Cardiac Imaging to Cut Costs and Improve Outcomes - Benzinga

Mar 03, 2026
pulisher
Mar 03, 2026

Merck (MRK) Partners with Tempus AI for Precision Oncology Advan - GuruFocus

Mar 03, 2026
pulisher
Mar 03, 2026

Merck to collaborate with Tempus AI on precision oncology - Seeking Alpha

Mar 03, 2026
pulisher
Mar 03, 2026

Tempus AI, Inc. Announces Strategic Collaboration Agreement with Merck to Accelerate AI-Driven Precision Medicine - marketscreener.com

Mar 03, 2026
pulisher
Mar 03, 2026

Tempus announces strategic collaboration agreement with Merck to accelerate AI-driven precision medicine - marketscreener.com

Mar 03, 2026
pulisher
Mar 03, 2026

Tempus AI, Merck Collaborate on AI-Driven Precision Medicine - marketscreener.com

Mar 03, 2026
pulisher
Mar 03, 2026

Tempus AI expands collaboration with Merck on precision medicine - Investing.com India

Mar 03, 2026
pulisher
Mar 03, 2026

Tempus Announces Strategic Collaboration Agreement With Merck To Accelerate Ai-Driven Precision Medicine - TradingView

Mar 03, 2026
pulisher
Mar 03, 2026

Tempus Announces Strategic Collaboration Agreement with Merck to Accelerate AI-Driven Precision Medicine - The Joplin Globe

Mar 03, 2026
pulisher
Mar 03, 2026

Tempus AI, Inc. $TEM Shares Bought by Mitsubishi UFJ Asset Management Co. Ltd. - MarketBeat

Mar 03, 2026
pulisher
Mar 03, 2026

34,648 Shares in Tempus AI, Inc. $TEM Acquired by Intech Investment Management LLC - MarketBeat

Mar 03, 2026
pulisher
Mar 02, 2026

Tempus AI (TEM) Is Down 6.9% After Raising 2026 Outlook And Filing ESOP Shelf Offering - simplywall.st

Mar 02, 2026
pulisher
Mar 02, 2026

Quantbot Technologies LP Buys Shares of 50,089 Tempus AI, Inc. $TEM - MarketBeat

Mar 02, 2026
pulisher
Mar 01, 2026

TEM (NASDAQ: TEM) insider sale files 870 restricted units - Stock Titan

Mar 01, 2026
pulisher
Mar 01, 2026

Tempus AI, Inc. (NASDAQ:TEM) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat

Mar 01, 2026
pulisher
Feb 27, 2026

After a Near 50% Drop, Tempus AI Could Be Ripe for a Rebound - MarketBeat

Feb 27, 2026
pulisher
Feb 27, 2026

Best Artificial Intelligence Stocks To ResearchFebruary 27th - MarketBeat

Feb 27, 2026
pulisher
Feb 27, 2026

Tempus AI Expands Oncology Portfolio With HRD-RNA And Lung Screening Deal - simplywall.st

Feb 27, 2026
pulisher
Feb 27, 2026

Dakota Wealth Management Has $1.06 Million Stock Holdings in Tempus AI, Inc. $TEM - MarketBeat

Feb 27, 2026
pulisher
Feb 26, 2026

Why Tempus AI (TEM) Is Down 7.5% After 2025 Results, 2026 Outlook And ESOP Shelf RegistrationAnd What's Next - Yahoo Finance

Feb 26, 2026
pulisher
Feb 26, 2026

How The Tempus AI (TEM) Investment Story Is Evolving With New Data And Valuation Views - Yahoo Finance

Feb 26, 2026
pulisher
Feb 26, 2026

Top Artificial Intelligence Stocks To Keep An Eye OnFebruary 26th - MarketBeat

Feb 26, 2026
pulisher
Feb 26, 2026

Is It Time To Reassess Tempus AI (TEM) After Recent Share Price Weakness? - Yahoo Finance

Feb 26, 2026
pulisher
Feb 26, 2026

Tempus AI: Buy The Post-Earnings Dip (NASDAQ:TEM) - Seeking Alpha

Feb 26, 2026
pulisher
Feb 26, 2026

Tempus AI CEO Eric Lefkofsky set for fireside chat at Morgan Stanley TMT event - Stock Titan

Feb 26, 2026
pulisher
Feb 26, 2026

Analysts Offer Insights on Healthcare Companies: Tempus AI, Inc. Class A (TEM), BridgeBio Pharma (BBIO) and Establishment Labs Holdings (ESTA) - The Globe and Mail

Feb 26, 2026
pulisher
Feb 25, 2026

Cathie Wood Is Buying The Tempus AI Dip, Ark Snaps Up Stock Worth $11 MillionTempus AI (NASDAQ:TEM) - Benzinga

Feb 25, 2026
pulisher
Feb 25, 2026

Tempus AI (TEM) Loss Deepens To US$0.30 EPS As Premium Valuation Thesis Faces Test - simplywall.st

Feb 25, 2026
pulisher
Feb 25, 2026

Cathie Wood’s ARK sells PagerDuty stock, buys Tempus AI By Investing.com - Investing.com India

Feb 25, 2026
pulisher
Feb 25, 2026

Cathie Wood’s ARK sells PagerDuty stock, buys Tempus AI - Investing.com

Feb 25, 2026
pulisher
Feb 25, 2026

[Form 3] Tempus AI, Inc. Initial Statement of Beneficial Ownership - Stock Titan

Feb 25, 2026
pulisher
Feb 25, 2026

Tempus AI sold off after a beat but the rebound case is building - MSN

Feb 25, 2026
pulisher
Feb 25, 2026

Tempus AI Sold Off After a Beat—But the Rebound Case Is Building - MarketBeat

Feb 25, 2026
pulisher
Feb 25, 2026

Tempus AI: No AI Interruption Detected (NASDAQ:TEM) - Seeking Alpha

Feb 25, 2026
pulisher
Feb 25, 2026

Promising Artificial Intelligence Stocks To Follow NowFebruary 25th - MarketBeat

Feb 25, 2026
pulisher
Feb 25, 2026

Tempus AI (TEM) Stock: Insider Selling Tops $37M as JPMorgan Cuts Price Target - CoinCentral

Feb 25, 2026
pulisher
Feb 25, 2026

JPMorgan Chase & Co. Issues Pessimistic Forecast for Tempus AI (NASDAQ:TEM) Stock Price - MarketBeat

Feb 25, 2026
pulisher
Feb 25, 2026

Tempus AI (NASDAQ:TEM) Price Target Cut to $75.00 by Analysts at Needham & Company LLC - MarketBeat

Feb 25, 2026
pulisher
Feb 25, 2026

Tempus AI (NASDAQ:TEM) Trading Down 7.4% After Analyst Downgrade - MarketBeat

Feb 25, 2026
pulisher
Feb 25, 2026

Stifel cuts Tempus AI stock price target to $60 on valuation - Investing.com

Feb 25, 2026
pulisher
Feb 25, 2026

Tempus AI Posts 83% Revenue Growth Yet Stumbles on Full Year Profitability Target - Yahoo Finance

Feb 25, 2026
pulisher
Feb 25, 2026

Tempus AI: Accelerating AI-Driven Precision Medicine Growth with Undervalued Long-Term Potential - TipRanks

Feb 25, 2026
pulisher
Feb 25, 2026

Tempus AI (NASDAQ:TEM) Price Target Lowered to $90.00 at BTIG Research - MarketBeat

Feb 25, 2026
pulisher
Feb 25, 2026

Tempus AI, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance

Feb 25, 2026
pulisher
Feb 25, 2026

TEM Q4 Earnings Miss, Revenues Beat, Stock Down in After-Market - Nasdaq

Feb 25, 2026

Tempus Ai Inc Azioni (TEM) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$41.51
price up icon 2.06%
health_information_services HQY
$82.46
price up icon 2.45%
health_information_services WAY
$26.84
price up icon 1.20%
$26.57
price down icon 1.48%
$46.09
price up icon 4.02%
Capitalizzazione:     |  Volume (24 ore):